Mol. Hum. Reprod. Advance Access originally published online on October 8, 2004
Molecular Human Reproduction 2004 10(12):901-909; doi:10.1093/molehr/gah118
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival
1Department of Pediatrics, Division of Neonatology and 2Program in Fetal Medicine, Women & Infants' Hospital of Rhode Island and Brown Medical School, Providence, RI 02905, USA
3 To whom correspondence should be addressed at: Department of Pediatrics, Women & Infants' Hospital, 101 Dudley St., Providence, RI 02905, USA. Email: mjaleel{at}wihri.org
Stromal cell-derived factor-1 (SDF-1 or CXCL12) is the physiologic ligand for the chemokine receptor CXCR4. CXCR4-mediated signalling regulates cell migration and apoptosis in certain haematopoietic and neuronal cells. Using gene profiling, we determined that CXCR4 is the only chemokine receptor for which mRNA expression is regulated during trophoblast differentiation in vitro. Based on the known effects of CXCR4 ligation, we hypothesized that CXCR4 activation may regulate placental trophoblast cell survival (i.e. protection from apoptosis), an important mechanism for the establishment and maintenance of the uteroplacental barrier. Human cytotrophoblasts (CTBs) were cultured in defined media and treated with graded doses of SDF-1 (10100 ng/ml) or with an anti-CXCR4 neutralizing antibody. Exposure to anti-CXCR4 antibody reduced CTB cell numbers by 2540%. Treatment with SDF-1 decreased the proportions of apoptotic terminal deoxynucleotidyl transferase-mediated dUTP-FITC nick-end labelling(+) cells (apoptotic index [AI] of 2.79±0.61% [control] versus 1.88±0.56% [SDF-1]; P<0.05) and caspase-activated cells (AI of 7.95±2.49% [control] versus 3.81±1.49% [SDF-1]; P<0.05). We determined that SDF-1 also activated the triple MAP Kinase isoforms ERK1/2 and p38 in trophoblasts. Immunocytochemistry confirmed SDF-1-induced nuclear translocation of phosphorylated ERK1/2. Blocking of ERK1/2 signalling with the specific inhibitor PD98059 reversed SDF-1-mediated inhibition of apoptosis (AI of 1.65±0.34 [SDF-1] versus 3.50±0.5 [SDF-1 + PD98059]; P<0.05), suggesting that SDF-1 acts through this pathway as a trophoblast survival factor. These results indicate that SDF-1/CXCR4 signalling stimulates anti-apoptotic pathways in cultured trophoblasts. This chemotactic ligand/receptor system may promote trophoblast survival during pregnancy. Alterations in SDF-1 and/or CXCR4 expression or function may be associated with specific pregnancy disorders.
Key words: apoptosis/chemokines/placenta/trophoblast
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Lin, H. Wang, W. Wang, S. Zeng, Y. Zhong, and D.-J. Li Prevention of embryo loss in non-obese diabetic mice using adoptive ITGA2+ISG20+ natural killer-cell transfer Reproduction, June 1, 2009; 137(6): 943 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Odemis, K. Boosmann, M. T. Dieterlen, and J. Engele The chemokine SDF1 controls multiple steps of myogenesis through atypical PKC{zeta} J. Cell Sci., November 15, 2007; 120(22): 4050 - 4059. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, S. Dai, W.-J. Wu, W. Tan, X. Zhu, J. Mu, Y. Guo, R. Bolli, and G. Rokosh Stromal Cell Derived Factor-1{alpha} Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell Derived Factor-1{alpha} CXCR4 Axis Circulation, August 7, 2007; 116(6): 654 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Li, C. Luo, M. Mines, J. Zhang, and G.-H. Fan Chemokine CXCL12 Induces Binding of Ferritin Heavy Chain to the Chemokine Receptor CXCR4, Alters CXCR4 Signaling, and Induces Phosphorylation and Nuclear Translocation of Ferritin Heavy Chain J. Biol. Chem., December 8, 2006; 281(49): 37616 - 37627. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Red-Horse, M. Kapidzic, Y. Zhou, K.-T. Feng, H. Singh, and S. J. Fisher EPHB4 regulates chemokine-evoked trophoblast responses: a mechanism for incorporating the human placenta into the maternal circulation Development, September 15, 2005; 132(18): 4097 - 4106. [Abstract] [Full Text] [PDF] |
||||




